News-2022 Archives - TriSalus Life Sciences

TriSalus Life Sciences Provides Update on Development of Immunotherapy Platform Approach for Liver and Pancreatic Tumors

by Jen Peters | Jun 22, 2022 | Home News (Left), News, News-2022

News & Events News TriSalus Life Sciences Provides Update on Development of Immunotherapy Platform Approach for Liver and Pancreatic Tumors DENVER and CHICAGO, JUNE 22, 2022 – TriSalus Life Sciences®, an immunotherapy company on a mission to extend and improve the...

TriSalus Life Sciences to Present at the Society of Interventional Radiology’s 2022 Annual Scientific Meeting

by Jen Peters | Jun 6, 2022 | Home News (Left), News, News-2022

News & Events News TriSalus Life Sciences to Present at the Society of Interventional Radiology’s 2022 Annual Scientific Meeting *** MEDIA ADVISORY *** BOSTON, June 6, 2022 – TriSalus Life Sciences®, an interventional immunotherapy company on a mission to extend and...

TriSalus Life Sciences Enrolls First Patient in PERIO-02 Clinical Trial, Studying the Delivery of SD-101 via Pressure-Enabled Drug Delivery in Adults with Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

by Jen Peters | May 10, 2022 | Home News (Right), News, News-2022

News & Events News TriSalus Life Sciences Enrolls First Patient in PERIO-02 Clinical Trial, Studying the Delivery of SD-101 via Pressure-Enabled Drug Delivery in Adults with Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma DENVER and CHICAGO, May 10, 2022...

TriSalus Life Sciences Opens Its First Research Laboratory on Lifespan Health System’s Campus

by Jen Peters | Apr 12, 2022 | Home News (Right), News, News-2022

News & Events News TriSalus Life Sciences Opens Its First Research Laboratory on Lifespan Health System’s Campus Immunotherapeutic collaboration will advance efforts to develop new treatment options for patients with liver and pancreatic tumors PROVIDENCE, R.I.,...

TriSalus Life Sciences Expands Clinical Executive Team and Scientific Advisors in Support of Company’s Focus to Overcome Liver and Pancreatic Cancer Treatment Barriers and Enable More Patients to Benefit From Immunotherapy

by Jen Peters | Feb 10, 2022 | News, News-2022

News & Events News TriSalus Life Sciences Expands Clinical Executive Team and Scientific Advisors in Support of Company’s Focus to Overcome Liver and Pancreatic Cancer Treatment Barriers and Enable More Patients to Benefit From Immunotherapy DENVER and CHICAGO,...

TriSalus Life Sciences Announces Collaboration with the University of Colorado Anschutz Medical Campus to Advance Research on Innovative Immuno-oncology Treatments for Patients With Liver and Pancreatic Tumors

by Jen Peters | Jan 19, 2022 | News, News-2022

News & Events News TriSalus Life Sciences Announces Collaboration with the University of Colorado Anschutz Medical Campus to Advance Research on Innovative Immuno-oncology Treatments for Patients With Liver and Pancreatic Tumors DENVER and AURORA, COLO., Jan., 20,...